Showing results (171-180 of 229) with videos related to

Sort By:
Pageof 23
Hepatology (Baltimore, Md.)|March 21, 1998
Open-label trial of oral nalmefene therapy for the pruritus of cholestasisN V Bergasa, J M Schmitt, T L Talbot, et al.
JHEP Reports : Innovation in Hepatology|March 11, 2026
Diabetes and obesity reduce FIB-4 accuracy in MASLD referral pathwaysAbdel-Aziz Shaheen, Elizabeth Baguley, Mark G Swain, et al.
Canadian Journal of Gastroenterology & Hepatology|July 23, 2016
Validation of the Model of End-Stage Liver Disease for Liver Transplant Allocation in Alberta: Implications for Future Directions in CanadaKelly W Burak, Glenda A Meeberg, Robert P Myers, et al.
Journal of Hepatology|August 1, 1994
Therapy of chronic hepatitis B with a 6-month course of ribavirinM W Fried, T L Fong, M G Swain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2005
Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cellsMaureen N Ajuebor, Alex I Aspinall, Feng Zhou, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|February 15, 2007
Induction versus noninduction antiviral therapy for chronic hepatitis C virus in patients with congenital coagulation disorders: a Canadian multicentre trialA Chatterjee, M G Swain, S S Lee, et al.
CMAJ Open|June 11, 2020
Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling studyMark G Swain, Alnoor Ramji, Keyur Patel, et al.
Pageof 23